PatternsRadar
Sign in

ANTHEMAnthem Biosciences Limited

NSE
951.05INR+14.25 (+1.52%)Close · 20 Nov 2026
3 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹53,607 CrMarket cap
87.3P/E (TTM)
54.8%Delivery

Filings & corporate actions

7 results filed
CSV
Next results · Q3 FY27
Expected 21 Jan 2027 – 19 Feb 2027
Estimate: filed 21–50 days after quarter end, last 6 times
Dividend
₹2.00 per share · last 25 Jun 2026
2026
  • 3 NovresultsResults · Q2 FY27 · consolidated and standalone+4.0%NSE
  • 13 OctshareholdingShareholding · 30 Sept 2026-1.5%NSE
  • 21 JulresultsResults · Q1 FY27 · consolidated and standalone-1.6%NSE
  • 17 JulshareholdingShareholding · 30 Jun 2026+2.4%NSE
  • 25 JundividendDividend · ₹2.00 per share-1.0%
  • 24 JunresultsResults · Q4 FY26 · consolidated-1.0%NSE
  • 20 MayresultsResults · Q4 FY26 · consolidated and standalone-0.9%NSE
  • 20 AprshareholdingShareholding · 31 Mar 2026+0.4%NSE
  • 5 FebresultsResults · Q3 FY26 · consolidated and standalone+2.8%NSE
  • 16 JanshareholdingShareholding · 31 Dec 2025-0.9%NSE

Reaction to results · all yearsrose on day 0 in 4 of 6 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY273 Nov 2026+4.0%+12.1%—2.8×
Q1 FY2721 Jul 2026-1.6%-0.2%+11.4%6.6×
Q4 FY2620 May 2026-0.9%-3.8%+1.4%6.8×
Q3 FY265 Feb 2026+2.8%+8.7%+4.0%1.3×
Q2 FY269 Nov 2025+1.2%-4.5%-6.8%3.8×
Q1 FY2613 Aug 2025+9.3%+9.0%+10.7%—
Average+2.5%+3.5%+4.1%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+8.0%
Profit YoY+21.9%
Interest cost YoY—
Revenue QoQ+42.0%
Profit QoQ+76.3%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

Open930.00
Day range929.00 – 954.85
52-week range579.15 – 989.10
From 52w high-3.8%
RSI (14)65.6
ATR (14)26.55
Volume3.29L
Avg volume (20D)4.22L
Rel volume0.78×
Volatility (1Y)29.0%
Turnover₹31.2Cr
Traded value (NSE)₹31.2Cr
VWAP946.94
SMA 50 / 200884.51 / 789.60
Price band20%

Delivery percentage

Latest · 20 Nov 202654.8%
20-day avg51.6%
1-year avg54.6%
Percentile (own history)63rd
Range18.0–89.1%
Sessions332

Over the last 20 sessions ANTHEM settled 51.6% of its traded quantity, which is above average for an NSE equity. Its one-year average is 54.6%, so recent sessions are running 2.9 points lower than usual. The latest session ranks higher than 63% of the 332 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.21%
Dividend, trailing 12M₹2.00
Paid every year for1 yr
Shareholders1.76L · +1.7% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buynever

Performance returns

1D1W1M3M6M1Y
Price+1.52%+1.50%+18.77%+8.75%+23.66%+40.09%

Valuation

Market cap₹53,607 Cr
Market cap (NSE)₹53,594 Cr
Free-float cap₹15,332 Cr
P/E (TTM)87.3
P/E (NSE)86.0
EPS (TTM)10.89
P/B16.3
Net margin (TTM)30.0%
Other income / PBT19.8%
ROE20.4%
Debt / equity0.01
Shares outstanding56.35Cr
Listed21 Jul 2025

Ownership

Promoter71.40%
Promoter Δ QoQ-0.02 pp
Public28.60%
FII3.79%
DII12.10%
Pledged0.00%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)423.2610.9418.2594.0
YoY chg——-22.6%+8.0%
Net profit (₹ Cr)92.8189.8119.9211.5
YoY chg——-11.7%+21.9%
Net margin21.9%31.1%28.7%35.6%
EPS1.646.682.113.72

Shareholding over time

By quarter

30 Sept 2026 · promoter 71.40% · public 28.60%
18 Jul 2025: promoter 74.69%30 Sept 2025: promoter 74.69%31 Dec 2025: promoter 74.69%31 Mar 2026: promoter 74.68%30 Jun 2026: promoter 71.42%30 Sept 2026: promoter 71.40%
2025-072026-09
  • Promoter
  • Public and others
Promoter
71.40%
Public
28.60%
Promoter change
-0.02 pp
Filed
13 Oct 2026
FII
3.79%
DII
12.10%
Promoter pledged
0.00%

Who the public is

Mutual funds
9.25%

-1.90 pp QoQ

Insurance
1.72%

+0.13 pp QoQ

FPI
3.79%

+1.22 pp QoQ

Retail ≤ ₹2L
1.83%

+0.05 pp QoQ

HNI > ₹2L
7.64%

0.00 pp QoQ

NRI
0.04%

+0.01 pp QoQ

Bodies corporate
0.37%

+0.12 pp QoQ

Shareholders
1,76,209

+1.7% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
AJAY BHARDWAJPromoter · Individual42.39%
ISHAAN BHARDWAJPromoter · Individual10.12%
GANESH SAMBASIVAMPromoter · Individual8.10%
K C RAVINDRAPromoter · Individual7.75%
PORTSMOUTH TECHNOLOGIES LLCCorporate2.73%
MALAY JIBAN BARUAIndividual2.26%
RUPESH NARHARRAO KINEKARIndividual2.26%
SATISH S SHARMAIndividual2.26%
HDFC MUTUAL FUND - HDFC BUSINESS CYCLE FUNDMutual fund1.90%
SBI MNC FUNDMutual fund1.75%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 25 Jun 2026 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹2.00₹2.00
Ex-dateRecord dateDeclaredAdjusted
25 Jun 2026—₹2.00₹2.00

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

52-week highs & lows

Loading…

Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
none on record
Disclosures on record
4
2 open-market of the newest 4
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
21 Sept 2026Viridity Tone LLPEmployeeSell9.00L₹82.7Cr918.6010.00L → 1.00L0.02%-0.18 pp7(2)told 21 Sept 2026
12 Mar 2026Viridity Tone LLPOtherSell2.03Cr₹1,255.2Cr617.932.13Cr → 10.00L0.18%-3.66 pp7(2)told 11 Mar 2026

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Filings

CSV
Loading…

Bulk & block deals · 18 Jun 2026

CSV
12 of 61 deals
By year
DateDealClientQuantityPriceValue
18 Jun 2026Sell · block, also bulkARUNA GANESH1.71Cr744.80₹1,274.7Cr
18 Jun 2026Buy · blockHDFC MUTUAL FUND13.43L744.80₹100.0Cr
18 Jun 2026Buy · blockKOTAK MAHINDRA MUTUAL FUND13.43L744.80₹100.0Cr
18 Jun 2026Buy · blockBAJAJ LIFE INSURANCE LIMITED12.08L744.80₹90.0Cr
18 Jun 2026Buy · blockICICI PRUDENTIAL LIFE INSURANCE COMPANY LIMITED12.08L744.80₹90.0Cr
18 Jun 2026Buy · blockSBI MUTUAL FUND10.78L744.80₹80.3Cr
18 Jun 2026Buy · blockPRUDENTIAL HONG KONG LIMITED10.20L744.80₹76.0Cr
18 Jun 2026Buy · blockPI OPPORTUNITIES AIF V LLP8.06L744.80₹60.0Cr
18 Jun 2026Buy · blockMAHINDRA MANULIFE MUTUAL FUND7.67L744.80₹57.2Cr
18 Jun 2026Buy · blockUTI MUTUAL FUND7.61L744.80₹56.6Cr
18 Jun 2026Buy · blockSBI MUTUAL FUND7.42L744.80₹55.3Cr
18 Jun 2026Buy · blockNORDEA 1 SICAV - INDIAN EQUITY FUND6.85L744.80₹51.0Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026
  • P/E > 50 (4 quarters) · since 22 Jul 2025 — P/E above 50 on the last four quarters’ earnings.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations540.2550.0423.2610.9418.2594.0
Other income22.848.233.551.224.958.9
Total income563.0598.3456.7662.2443.1652.9
Total expenses376.8368.7300.8385.2298.5356.6
└ Finance costs1.63.00.41.90.93.3
└ Depreciation26.433.534.539.630.030.7
Profit before tax186.2229.6130.5277.9144.6296.4
Tax expense50.556.237.788.224.684.9
Net profit135.8173.492.8189.8119.9211.5
EPS2.433.091.656.762.133.75
Net margin25.14%31.53%21.93%31.06%28.68%35.60%
PBT margin34.48%41.74%30.83%45.49%34.57%49.89%
Tax rate27.09%24.47%28.86%31.72%17.04%28.65%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 3 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 H1 FY26FY26H1 FY27
Total assets3,284.33,429.33,686.4
Current assets2,184.11,803.11,881.0
└ Cash & equivalents503.8272.920.0
└ Other bank balances68.42.00.7
└ Current investments527.6665.6684.7
└ Trade receivables577.3590.6527.2
└ Inventories185.8124.5188.6
Total equity2,752.53,042.53,281.0
└ Attributable to owners2,752.53,042.53,281.0
└ Non-controlling interest0.0—0.0
└ Share capital112.3112.3112.7
Borrowings106.451.138.7
└ Current69.123.319.0
└ Non-current37.427.719.7
Trade payables77.675.2165.2
Current liabilities464.1325.7340.4
Total liabilities531.8386.8405.4
Net debt(993.4)(889.4)(666.7)
Debt / equity0.040.020.01
Current ratio4.715.545.53

Cash flow, year to date

 H1 FY26FY26H1 FY27
Operating cash flow402.5844.5318.2
└ Capex(94.3)(211.2)(110.4)
Free cash flow308.3633.3207.8
Investing cash flow(168.6)(701.6)(207.2)
Financing cash flow21.3(40.0)(108.4)
└ Dividends paid0.00.0(112.7)
└ Buybacks0.00.00.0
Net change in cash255.2102.62.5

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

ANTHEM at a glance

  • ANTHEM closed at ₹951.05 on 20 Nov 2026, +1.52% on the day, +40.1% over one year, 3.8% below its 52-week high of ₹989.1.
  • Delivery was 54.8% of traded quantity on 20 Nov 2026, the 63rd percentile of its own 332 sessions with a reading (20-session average 51.6%, 1-year average 54.6%).
  • Market capitalisation is ₹53,607 crore at a trailing P/E of 87.3 (trailing EPS ₹10.89).
  • Q2 FY27 results (consolidated, filed 3 Nov 2026): revenue ₹594 crore (+8.0% year on year), net profit ₹211 crore (+21.9%); the price moved +4.0% on the first session after.
  • Promoters held 71.40% at 30 Sept 2026, down 0.02 percentage points on the previous filing.
  • Q3 FY27 results are expected between 21 Jan 2027 and 19 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryBiotechnology
ISININE0CZ201020
SeriesEQ
Listed21 Jul 2025
IPO price570.00 · band Rs.540 to Rs.570
IPO listing21 Jul 2025
NSE market cap · 17 Nov 2026₹52,097 Cr
Free-float market cap (NSE)₹9,949 Cr
Shares outstanding (NSE)56.37Cr
History from21 Jul 2025
Sessions332
Turnover rank#508

Sector history

  1. to 16 Aug 2026Index industry · Healthcare
  2. from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Biotechnology

NSE’s own classification, by the snapshot it changed on.

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.